2020
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
Which pharma company seeks permission from DGCI for ‘phase 2 & 3’ clinical trials of Oxford vaccine under brand name “Covishield” in India?
|
|
Indian Immunologicals
|
|
|
Indian Drugs and Pharmaceuticals Limited
|
|
|
Serum Institute of India
|
|
|
Bharat Biotech
|
Explanation:
There is 1 question to complete.